Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

8.71
Delayed Data
As of Oct 23
 -0.13 / -1.47%
Today’s Change
6.90
Today|||52-Week Range
11.63
+1.63%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues66.5M87.1M99.8M244.1M
 
 
 
 
 
Cost of Goods Sold30.5M42.8M51.8M114.9M
 
 
 
 
 
Depreciation And Amortization4.4M5.6M7.1M23.2M
 
 
 
 
 
 
Operating ExpensesGross Income31.5M38.6M40.9M106.0M
 
 
 
 
 
General Expenses28.3M36.0M41.8M99.9M
 
 
 
 
 
Research And Development2.2M2.4M4.0M4.4M
 
 
 
 
 
Total Operating Expenses63.3M84.5M100.7M238.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income3.2M2.6M-935.0K6.0M
 
 
 
 
 
Extraordinary Charge0.00-361.0K-4.7M-3.5M
 
 
 
 
Interest Expense On Debt989.0K929.0K854.0K10.0M
 
 
 
 
 
Other Expenses0.000.002.0M0.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income2.2M1.3M-4.5M-7.4M
 
 
 
 
 
Income Taxes-152.0K-157.0K-2.0M-1.7M
 
 
 
 
 
Preferred Dividend0.000.00-122.0K-24.7M
 
 
 
Net Income2.0M1.1M-2.5M-5.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS48.3M53.5M60.5M77.5M
 
 
 
 
 
Shares To Calculate EPS Diluted52.8M56.0M60.5M77.5M
 
 
 
 
 
 
Earnings Per ShareEPS$0.04$0.02-$0.04-$0.39
 
 
 
 
 
EPS Diluted$0.04$0.02-$0.04-$0.39